Penicillin and Streptomycin Market Trends, Size, Competitive Analysis and Forecast - 2019-2025

Global penicillin and streptomycin market is expected to grow with a CAGR of 0.3% during the forecast period. Penicillin and streptomycin are defined as a class of antibiotics that are used to kill bacterial infection and restrict bacterial growth. World Health Organization (WHO) included it in its list of essential medicines which are the most effective and safe medicines that are required in the healthcare system. Penicillin has been significantly used to treat infection, meningitis and so on. Streptomycin has been significantly used for the treatment of tuberculosis. Rising use of antibiotics in cell culture is offering an opportunity for the growth of the market. Antibiotics are frequently added to cell culture media as it suppresses contamination. The most common antibiotics for the cultivation of cells include a combination of penicillin and streptomycin. Many cell culture laboratories routinely add antibiotics and antimycotics to all cell culture media during the establishment of a primary culture, or while propagating specific valuable stocks or to eliminate any contamination.

Request a free sample of our report on Penicillin and Streptomycin Market: https://www.omrglobal.com/request-sample/penicillin-and-streptomycin-market

Several pharmaceutical companies have started to specifically introduce penicillin and streptomycin solutions for cell culture applications, such as Lonza AG and Thermo Fisher Scientific, Inc. Thermo Fisher Scientific, Inc. offers an antibiotic solution that contains Penicillin-Streptomycin-Glutamine and µg/mL of streptomycin that are used to prevent bacterial contamination of cell cultures due to their efficient combined action against gram-negative and gram-positive bacteria. As the cell culture researches are growing significantly, the demand for penicillin and streptomycin in cell culture is anticipated to grow in the near future. However, patent expiration and availability of substitute products are creating hurdles in the growth of the market.

A full report of Penicillin and Streptomycin Market Is available at https://www.omrglobal.com/industry-reports/penicillin-and-streptomycin-market

Global Penicillin and Streptomycin Market
Segmentation
By Product
• Penicillin
• Streptomycin

By Manufacturing Process
• Penicillin
o Natural Process
o Synthetic Process
o Semi-Synthetic Process

• Streptomycin
o Natural Process
o Synthetic Process
o Semi-Synthetic Process

By Route of Administration
• Oral
• Intramuscular
• Intravenous

By End-User
• Hospitals
• Clinics
• Others (Clinical Laboratories)

Regional Analysis
• North America
o US
o Canada

• Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe

• Asia-Pacific
o China
o India
o Japan
o Rest of Asia-Pacific

• Rest of the World

Company Profiles
• Abbott Laboratories, Inc.
• Alembic Pharmaceuticals, Ltd.
• Astellas Pharma, Inc.
• Bayer AG
• Biogen International GmbH
• Bristol-Myers Squibb Co.
• Corden Pharma GmbH
• Eli Lilly & Co.
• F. Hoffmann La Roche, Ltd.
• GlaxoSmithKline PLC

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/penicillin-and-streptomycin-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.